1 in 3 Children Now Suffer From Chronic Illness
Medically reviewed by Drugs.com.
By Dennis Thompson HealthDay Reporter
MONDAY, March 17, 2025 -- Nearly 1 in 3 children live with a chronic condition that could significantly affect their health for the rest of their lives, a new study says.
Chronic illnesses affected more than 30% of children ages 5 to 17 by 2018, up from around 23% in 1999, researchers report in the journal Academic Pediatrics.
This adds up to about 130,000 more children each year being diagnosed with a chronic illness.
This increase has been driven by diagnoses of ADHD/ADD, autism, asthma, prediabetes and mood disorders like depression or anxiety, lead researcher Lauren Wisk, an assistant professor of medicine at the David Geffen School of Medicine at UCLA, said in a news release.
“The prevalence of childhood conditions is currently higher than previous estimates suggest,” she said. “Youth who are subject to socioeconomic vulnerability such as having less education, lower income, are on public insurance, or unemployed are all more likely to live with a chronic condition than youth with socioeconomic advantages.”
For the study, researchers analyzed data on more than 236,000 people between 5 and 25 years of age who participated in the National Health Interview Survey between 1999 and 2018.
The results also showed that chronic illness increased among 18- to 25-year-olds, rising from about 19% to 29% between 1999 and 2018 -- an additional 80,000 young adults per year.
Nearly all these conditions are treatable with access to high-quality health care, but many children don’t have that access, Wisk said.
“Most youth with chronic conditions need to access health and social services for the rest of their lives, but our health system is not set up to successfully move young people from pediatric to adult focused care and so many of these youth are at risk of disengaging with care and experiencing disease exacerbations,” she said.
“We should invest in assisting these youth in engaging appropriately with healthcare across their lifespan in order to protect their health and well-being, and to facilitate their maximum participation in society with respect to education, vocation, social groups, and community spaces,” Wisk concluded.
Sources
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
Source: HealthDay
Posted : 2025-03-18 00:00
Read more

- Biogen Initiates Phase 3 Study of Felzartamab for the Treatment of Late Antibody-Mediated Rejection (AMR) in Kidney Transplant Patients
- Number of Family Caregivers Supporting Older Adults Increasing
- Newborns With Seizures At Greater Risk of Epilepsy
- 1 in 3 Kids Has Dental Problems, Poll Finds
- Innate Pharma Announces U.S. FDA Granted Breakthrough Therapy Designation to Lacutamab for Relapsed or Refractory Sézary Syndrome
- Opus Genetics Announces FDA Fast Track and Enrollment Updates for Phentolamine Ophthalmic Solution 0.75% Programs
Disclaimer
Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.
The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Popular Keywords
- metformin obat apa
- alahan panjang
- glimepiride obat apa
- takikardia adalah
- erau ernie
- pradiabetes
- besar88
- atrofi adalah
- kutu anjing
- trakeostomi
- mayzent pi
- enbrel auto injector not working
- enbrel interactions
- lenvima life expectancy
- leqvio pi
- what is lenvima
- lenvima pi
- empagliflozin-linagliptin
- encourage foundation for enbrel
- qulipta drug interactions